Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* With confirmed diagnosis of Crohn's disease~* Adalimumab-naïve patient (a patient having received an anti-TNF other than adalimumab may enter the study)~* Starting a treatment with adalimumab~* Guardian capable of and willing to grant authorization for use/disclosure of data collected and patient able to comply with the requirements of the study protocol.~Exclusion Criteria:~* Participants with a history of treatment with adalimumab~* Participants enrolled in a concomitant interventional clinical trial.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Pediatric participants receiving adalimumab (Type: None): Pediatric participants receiving adalimumab for CD in real-life conditions.

Based on this trial design, predict the completion outcome and termination type (if applicable).